India remains a preferred outsourcing destination, with a 30–35 per cent cost advantage over Western competitors. Emerging ...

The development may temporarily delay the approval of pending product submissions from the site, but existing manufacturing ...

(NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today reported financial results for the year ended December 31, 2024 and highlighted recent ...

A listeria outbreak tied to supplement shakes is now linked to at least 12 deaths and 38 cases across 21 states, according to ...

Research and development (R&D) expenses: R&D expenses were $81.8 million and $58.8 million for the quarters ended December 31, 2024 and 2023, respectively. R&D expenses were $281.4 million and $210.8 ...

Pan-Yoruba socio-cultural organisation, Afenifere, has called on the Federal Government to beef up security around staffers and Director General of National Agency for Food and Drugs Administration ...

The change in leadership comes shortly after Indivior warned that it is expecting a sharp decline in its revenues in 2025, ...

Health experts caution that certain everyday supplements can harm kidney function long before symptoms appear. Learn which ...